You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

NOVAMINE 11.4% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Novamine 11.4% patents expire, and what generic alternatives are available?

Novamine 11.4% is a drug marketed by Hospira Inc and is included in one NDA.

The generic ingredient in NOVAMINE 11.4% is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Novamine 11.4%

A generic version of NOVAMINE 11.4% was approved as amino acids by B BRAUN on April 13th, 2012.

  Try a Trial

Summary for NOVAMINE 11.4%
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:NOVAMINE 11.4% at DailyMed
Drug patent expirations by year for NOVAMINE 11.4%

US Patents and Regulatory Information for NOVAMINE 11.4%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc NOVAMINE 11.4% amino acids INJECTABLE;INJECTION 017957-003 Aug 9, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.